The Board

MARRES is designed and managed by an interdisciplinary board. Each member is specialist in a particular ocean-related field, i.e. Marine Ecology & ConservationEcophysiology & EcotoxicologyBiomedical potentialChemistry & BiotechnologyOcean & Society connectionLaw & Governance of the Sea and Entrepreneurship & Innovation tools. Christophe Mocquet & Paola Furla are the two directors of the program.

Dr. Christophe MOCQUET

Pr. Paola FURLA

  • Fonctions
  • Head
  • Prix et distinctions
  • Université de Nice

Dr. Steeve COMEAU

Steeve is a marine biologist – biogeochemist CNRS research scientist, working in the Laboratoire d’Océanographie de Villefranche sur Mer. He earned his Ph.D. from the University of Pierre and Marie Curie in Paris working on the effects of ocean acidification on pteropods in the Mediterranean and Arctic seas. From 2011 to 2017, his research focused on the biogeochemical and biological effects of global change on coral reefs, mainly on corals and coralline algae from Australia, French Polynesia, Hawaii and Okinawa, Japan. He moved back to France in the Laboratoire d’Océanographie de Villefranche sur Mer in January 2018 to work on the effects of environmental drivers on Mediterranean benthic ecosystems.

  • Fonctions
  • Prix et distinctions
  • CNRS

Dr. Yan GRASSELLI

  • Fonctions
  • Chercheur associé
  • Prix et distinctions
  • SKEMA Business School
  • Université de Nice

Pr. Jean-Christophe MARTIN

Jean Christophe is director of the Institute for Peace and Development Law and member of the LADIE lab (Laboratoire de droit international et européen). He is Vice President for International Affairs at UCA. With MARRES, he develops the law modules, in particular "Marine Resource and Environment Law".

  • Fonctions
  • Prix et distinctions
  • Université de Nice
  • Université Côte d'Azur

Dr. Mohamed MEHIRI

The Marine Natural Products theme focuses on the different aspects of the chemistry of natural substances with, mainly, the characterization and production of small natural molecules identified as secondary metabolites of marine invertebrates and microorganisms. Many marine organisms, particularly invertebrates that are often associated with symbiotic microorganisms, represent an under-explored source of new natural products that are responsible for a variety of biological activities in situ (antibiotic, antifungal, anti-fouling, etc.). same as valuation. These secondary metabolites frequently have original structures, often bioactive, different from those of the terrestrial environment. These are tools used in ecophysiology (toxins), biology (taxonomy), pharmacology or cosmetics. In the search for new therapeutic agents from the sea, about twenty molecules are at various stages of the clinical phase and five drugs of marine origin are currently marketed. The latest anti-cancer drugs are Trabectedine® (or Yondelis, PharmaMar ™), isolated from the colonial ascidian Ecteinascidia turbinata, and Halaven® (or Eribuline mesylate, EISA ™), a synthetic halichondrin B analog isolated from the sponge. marine Halichondria okadai, marketed in 2007 and 2010.

Dr. Eric ROTTINGER